GAP Production of TCM Herbs in China

Abstract

In this paper, we briefly review international Good Agricultural Practice (GAP) regulations related to traditional Chinese medicine herbs (TCM herbs) and the background of the drafting process and the implementation of GAP for TCM herbs in China. We also have summarized progress and achievements since the implementation of GAP for TCM herbs in 2002. Up to 2010, a total of 99 GAP bases were formally adopted by GAP certification. They cover 22 provinces/municipalities, and 49 species of TCM herbs are currently cultivated in these GAP bases. Finally, we discuss the main problems in GAP implementation for Chinese crude drugs and put forward some suggestions to tackle them.

Key words

GAP - TCM herbs - GAP base - China - cultivation

References

• 1 Ren D Q, Zhou R H. Good agricultural practice (GAP) implementation guide for Chinese Crude Drug. Beijing; China Agricultural Press 2003
• 2 Qin L P, Huang B K, Zheng H C. The background, present situation, problem and tactics of GAP of Chinese materia medica.  J Pharm Pract. 2001;  19 67-70
• 3 Yao L, Cheng H Z, Yang Z. Guidelines for good agricultural practice of Chinese crude drugs. Beijing; China Agriculture Press 2006
• 4 Wei J H, Chen S L. GUO QS . Analysis on GAP implementation of China's current situation and development.  Res Inf Tradit Chin Med. 2004;  6 4-8
• 5 Zheng Y C, Bao C Y. Industry improved by science and technology–Exhibition of industrial base construction of Jilin traditional Chinese medicine modernization. Beijing; Science and Technology Daily November.30.2009
• 6 Chen S L. Sustaining Herbal Supplies: China. Sharing innovative experiences (Vol. 10): examples of the development of pharmaceutical products from medicinal Plants. New York; UNDP 2005: 157-163
• 7 Liu S, Wei J H, Chen S L. Study on criteria for GAP certification of wild tending species of Chinese crude drug.  Chin Med J Res Pract. 2005;  7 1-4
• 8 Ran M X. The developmental situation and prospect of planting Chinese material medica in China.  Mod Chin Med. 2008;  10 3-6
• 9 Liu Y H. National S & T development strategy for modernization of traditional Chinese medicine.  Mod Tradit Chin Med Mater Med. 2005;  7 1-4
• 10 Yu P M, Wang J H, Li H, Zhang N. Probe on the industrialization pattern of Chinese material medica in GAP times.  Lishizhen Med Mater Med Res. 2007;  17 665-666
• 11 Wang J Q, Zhang A, Liu Y L, Lu D G, Zhang B, Cui J H. Countermeasures and proposals for implement of GAP normalized cultivation of Chinese medicinal materials.  Mod Tradit Chin Med Mater Med. 2005;  7 74-77
• 12 Zhu L X. The relationship research of the Chinese medicine herbs implement GAP cultivation and the superior medicine herbs.  Lishizhen Med Mater Med Res. 2006;  17 F0003-F0004
• 13 Liu Y M, Feng Q J, Niu X. The characters and problems of Chinese GAP cultivation of traditional medical material.  J Shanxi Coll Tradit Chin Med. 2002;  3 46-48
• 14 Li L Y, Xiao X H, Win S Y. Probe on the formation and differentiation of “Dao Di” Chinese crude drug.  Chin J Tradit Med Sci Technol. 1996;  6 104-106
• 15 Huang L Q, Zhang R X. Biological investigation on the “Dao Di” Chinese crud drug.  Chin Pharm J. 1997;  32 563-566
• 16 Ding L W. Why did the price of Schisandra chinesis plunge so quickly? – The marketing analysis of this species between 2000 and 2010.  Mod Chin Med. 2009;  11 48-50
• 17 Kong L, Qin J X. GAP is a propeller making traditional Chinese medicine into the world.  Chin Pharmacol. 2003;  12 7-9